PT Kalbe Farma Tbk. (IDX:KLBF)

Market Cap	53.02T
Revenue (ttm)	34.38T
Net Income (ttm)	3.49T
Shares Out	45.32B
EPS (ttm)	76.64
PE Ratio	15.27
Forward PE	14.16
Dividend	36.00 (3.03%)
Ex-Dividend Date	Jun 4, 2025

Volume	50,712,900
Average Volume	222,517,935
Open	1,170.00
Previous Close	1,170.00
Day's Range	1,165.00 - 1,180.00
52-Week Range	985.00 - 1,600.00
Beta	0.02
RSI	44.80
Earnings Date	Feb 18, 2026

About PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company pro...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1966
• Employees: 12,903
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: KLBF

Financial Performance

In 2024, PT Kalbe Farma Tbk.'s revenue was 32.63 trillion, an increase of 7.16% compared to the previous year's 30.45 trillion. Earnings were 3.24 trillion, an increase of 17.13%.